Notch control of cell architecture: Potential implications for future cancer therapy

October 5, 2012, CORDIS
Notch control of cell architecture
Credit: Thinkstock

Dissecting the mechanisms implicated in cell architecture should provide new insights for understanding development and tissue morphogenesis in general. An European study focused on the role of the Notch signalling pathway in regulating cell architecture.

The Notch pathway is a cell communication pathway conserved throughout the animal kingdom and is implicated in various developmental processes as well as linked to many diseases including cancer. Apart from its role in control, the is believed to regulate the cytoskeleton and . However, the precise mechanism by which Notch exerts its effects on these processes remains elusive.

The 'Understanding Notch function in cell architecture regulation' (NOTCH AND CELL ARCH) proposal therefore aimed to identify and analyse new Notch involved in cell architecture regulation.

By performing a genome-wide analysis of Notch-regulated genes, it was possible to identify genes coding for key proteins involved in cell morphology. These were categorised according to whether they presented changes in expression or they were located in proximity to a genomic region occupied by the transcription factor Su(H) which is known to mediate Notch responses. This led to the identification of 30 potential Notch targets with function related to cell behaviour regulation.

The function of these targets was tested using assays based on and differentiation during oogenesis, myogenesis and formation of the Drosophila wing disc. Using the technology of (RNAi) to knock down gene expression, scientists identified nine genes whose depletion induced phenotypes associated with muscle formation defects, and two others (Moesin and Chickadee) that were required for the proper organisation of the wing disc.

The role of Notch in controlling the expression of cytoskeletal and cell behaviour regulators was also evaluated. Genomic analysis of three (Reck, Rhea/Talin and Trio) for Su(H) and Twist binding positions is expected to provide important information regarding the implication of Notch in their transcription regulation.

Overall, the outcomes of the NOTCH AND CELL ARCH project offered new knowledge on the role of the Notch signalling pathway in cell architecture. Given the importance of Notch signalling and cell organisation integrity in many cancers, these new identified factors might have important implications for future therapy.

Explore further: Scientists find new mechanism by which cell signaling pathway contributes to rheumatoid arthritis development

Related Stories

Scientists find new mechanism by which cell signaling pathway contributes to rheumatoid arthritis development

May 20, 2012
A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence ...

Penn researchers describe key molecule that keeps immune cell development on track

August 8, 2011
In the latest issue of Nature, researchers at the Perelman School of Medicine at the University of Pennsylvania clarify the role of two proteins key to T-cell development. They found that one well-known protein called Notch ...

Key growth factor identified in T cell leukemia

August 1, 2011
Blocking a growth factor receptor cripples cancer growth in a form of T cell leukemia, according to a study published online on August 1 in the Journal of Experimental Medicine.

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.